Pharmacogenomic considerations in opioid analgesia
Pascal H Vuilleumier,1 Ulrike M Stamer,1 Ruth Landau21Klinik für Anästhesiologie und Schmerztherapie, Inselspital Universität Bern, Switzerland; 2Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USAAbstra...
Main Authors: | Vuilleumier PH, Stamer UM, Landau R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-08-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Online Access: | http://www.dovepress.com/pharmacogenomic-considerations-in-opioid-analgesia-a10790 |
Similar Items
-
 Pharmacogenomic considerations in opioid analgesia. [Corrigendum]
by: Vuilleumier PH, et al.
Published: (2013-01-01) -
An analysis of analgesia and opioid prescribing for veterans after thoracic surgery
by: Matthew J. Pommerening, et al.
Published: (2020-07-01) -
Landmarks of pharmacogenomics and some considerations for clinical practice
by: David Nana Ampong
Published: (2019-12-01) -
Meperidine: opioid not indicated for analgesia
by: Andresa Graciutti Botan, et al. -
General considerations for integrating pharmacogenomics into mainstream medical practice
by: Patrinos George P
Published: (2010-08-01)